Pancreatic Cancer Research

ResearcherBoston UniversityNo recent work listed

Anurag Singh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0003-4705-8683; OpenAlex author ID A5017482731; NIH RePORTER profile ID 8734785. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
2
Labs led
1
Collaborators
4
Papers, trials and grants by year

2011: 1 grant · 2012: none · 2013: none · 2014: 1 grant · 2015: none · 2016: 1 paper · 2017: 1 paper

Papers 2

  1. STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines. Last author DOI 10.18632/oncotarget.20833↗
  2. Molecular Pathogenesis of Pancreatic Cancer. Last author DOI 10.1016/bs.pmbts.2016.09.008↗

Grants 2

  1. Defining lineage-specific determinants of K-Ras "addiction" in human cancers R00CA149169↗
  2. Defining lineage-specific determinants of K-Ras "addiction" in human cancers K99CA149169↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Trevor J. Grant · 2 shared papers, 2016–2017 · strength 0.16
  2. David Tsai Ting · 1 shared paper, 2017 · strength 0.06
  3. Vikram Deshpande · 1 shared paper, 2017 · strength 0.06
  4. Nabeel M. Bardeesy · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.